Literature DB >> 19109339

Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosis.

Richard A Slayden1, John T Belisle.   

Abstract

OBJECTIVES: Universally conserved events in cell division provide the opportunity for the development of novel chemotherapeutics against Mycobacterium tuberculosis. The aim of this study was to use the beta-lactam antimicrobials cefalexin and piperacillin to inhibit FtsI and characterize the morphological changes and global transcriptional activities of genes to identify a signature response to FtsI inactivation.
METHODS: Cefalexin and piperacillin were used to block cell division, and microscopy was used to evaluate the effects on bacterial morphology and ultrastructure. Global transcriptional analysis was performed to determine the impact of FtsI inhibition on cell cycle processes and to identify molecular markers.
RESULTS: Inhibition of FtsI with cefalexin and piperacillin resulted in filamentous cells with multiple concentric rings and occasional branching as visualized by light and electron microscopy. Whole genome microarray-based transcriptional profiling and transcriptional mapping allowed the evaluation of cell cycle processes in response to inhibition of FtsI and characterization of transcriptional response and cell cycle processes.
CONCLUSIONS: This study substantiated that FtsZ-ring constriction and septal resolution require the transpeptidase activity of FtsI, making FtsI essential for cell division in M. tuberculosis. Therefore, FtsI is a target for drug discovery, and these studies provided a molecular signature of FtsI inactivation that can be applied to screening strategies for novel FtsI inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109339      PMCID: PMC2721702          DOI: 10.1093/jac/dkn507

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs.

Authors:  C E Barry; R A Slayden; A E Sampson; R E Lee
Journal:  Biochem Pharmacol       Date:  2000-02-01       Impact factor: 5.858

2.  FtsZ ring formation without subsequent cell division after replication runout in Escherichia coli.

Authors:  B Gullbrand; K Nordström
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

Review 3.  Tuberculosis drug targets.

Authors:  Ying Zhang; L Mario Amzel
Journal:  Curr Drug Targets       Date:  2002-04       Impact factor: 3.465

4.  Probing the catalytic activity of a cell division-specific transpeptidase in vivo with beta-lactams.

Authors:  Christian Eberhardt; Lars Kuerschner; David S Weiss
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

5.  Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates.

Authors:  Richard E Lee; Marina Protopopova; Emma Crooks; Richard A Slayden; Marianne Terrot; Clifton E Barry
Journal:  J Comb Chem       Date:  2003 Mar-Apr

Review 6.  Cytokinesis in bacteria.

Authors:  Jeffery Errington; Richard A Daniel; Dirk-Jan Scheffers
Journal:  Microbiol Mol Biol Rev       Date:  2003-03       Impact factor: 11.056

7.  Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.

Authors:  M Wilson; J DeRisi; H H Kristensen; P Imboden; S Rane; P O Brown; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

8.  Motility and chemotaxis of filamentous cells of Escherichia coli.

Authors:  N Maki; J E Gestwicki; E M Lake; L L Kiessling; J Adler
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

9.  Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery.

Authors:  Laurel Respicio; Pravin A Nair; Qing Huang; Burcu Anil; Sylvia Tracz; James J Truglio; Caroline Kisker; Daniel P Raleigh; Iwao Ojima; Dennis L Knudson; Peter J Tonge; Richard A Slayden
Journal:  Tuberculosis (Edinb)       Date:  2008-05-13       Impact factor: 3.131

Review 10.  Assembly dynamics of the bacterial cell division protein FTSZ: poised at the edge of stability.

Authors:  Laura Romberg; Petra Anne Levin
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

View more
  13 in total

Review 1.  Genetic Approaches to Facilitate Antibacterial Drug Development.

Authors:  Dirk Schnappinger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

Review 2.  How sisters grow apart: mycobacterial growth and division.

Authors:  Karen J Kieser; Eric J Rubin
Journal:  Nat Rev Microbiol       Date:  2014-07-07       Impact factor: 60.633

3.  MadR1, a Mycobacterium tuberculosis cell cycle stress response protein that is a member of a widely conserved protein class of prokaryotic, eukaryotic and archeal origin.

Authors:  Rebecca Crew; Melissa V Ramirez; Kathleen England; Richard A Slayden
Journal:  Tuberculosis (Edinb)       Date:  2015-03-13       Impact factor: 3.131

4.  A role for the class A penicillin-binding protein PonA2 in the survival of Mycobacterium smegmatis under conditions of nonreplication.

Authors:  Maria-Magdalena Patru; Martin S Pavelka
Journal:  J Bacteriol       Date:  2010-04-16       Impact factor: 3.490

5.  Transposon mutagenesis in Mycobacterium abscessus identifies an essential penicillin-binding protein involved in septal peptidoglycan synthesis and antibiotic sensitivity.

Authors:  Chidiebere Akusobi; Bouchra S Benghomari; Junhao Zhu; Ian D Wolf; Shreya Singhvi; Charles L Dulberger; Thomas R Ioerger; Eric J Rubin
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

6.  A PubMed-wide associational study of infectious diseases.

Authors:  Vitali Sintchenko; Stephen Anthony; Xuan-Hieu Phan; Frank Lin; Enrico W Coiera
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis.

Authors:  Susan E Knudson; Kunal Kumar; Divya Awasthi; Iwao Ojima; Richard A Slayden
Journal:  Tuberculosis (Edinb)       Date:  2014-04-01       Impact factor: 3.131

8.  Mycobacterium tuberculosis septum site determining protein, Ssd encoded by rv3660c, promotes filamentation and elicits an alternative metabolic and dormancy stress response.

Authors:  Kathleen England; Rebecca Crew; Richard A Slayden
Journal:  BMC Microbiol       Date:  2011-04-19       Impact factor: 3.605

9.  Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteria.

Authors:  Michael C Chao; Karen J Kieser; Shoko Minami; Daniela Mavrici; Bree B Aldridge; Sarah M Fortune; Tom Alber; Eric J Rubin
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

10.  Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.

Authors:  A S Trigos; B W Goudey; J Bedő; T C Conway; N G Faux; K L Wyres
Journal:  mSphere       Date:  2021-05-28       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.